Drug application
MIRALAX (POLYETHYLENE GLYCOL 3350)
Drugs@FDA NDA 022015 · BAYER HEALTHCARE LLC
Key facts
| Drug name | MIRALAX |
|---|---|
| Active ingredients | POLYETHYLENE GLYCOL 3350 |
| Application type | NDA |
| Application number | 022015 |
| Company | BAYER HEALTHCARE LLC |
| Dosage forms | FOR SOLUTION, ORAL |
| Strength | 17GM/SCOOPFUL |
| Marketing status | Over-the-counter |
| Reference listed drug | Yes |
| Latest submission class | Type 8 - Partial Rx to OTC Switch |
| Latest submission status date | Oct 6, 2006 |
At a glance
- 1–9 Submissions
- 10–99 Supplements
- 10–99 Label versions
- 1–9 Products
- None Therapeutic equivalents
- Yes FDA letters on file
- Yes FDA reviews on file
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Drugs@FDA applications
Drugs@FDA covers FDA-approved brand-name and generic drugs and therapeutic biologics, with their applications (NDA, ANDA or BLA), products, submissions and labels.
Source: U.S. Food and Drug Administration (FDA), Drugs@FDA · Source date: